Читать книгу Assisted Reproduction Techniques - Группа авторов - Страница 188

1 1 cancerresearchuk.org>health‐professional>breast cancer: Cancer Research UK ‐Office for National Statistics. Cancer survival in England: adults diagnosed in 2009 to 2013, followed up to 2014.

2 2 cancerresearchuk.org>health‐professional>Hodgkin‐lymphoma: Cancer Research UK.

3 3 Borchmann P, Topp MS, Behringer K, et al. Dacarbazine is an essential component of ABVD in the treatment of early favourable Hodgkin Lymphoma: results of the second interim analysis of the GHSG HD 13 trial. Onkologie. 2010; 33:124–5.

4 4 Meirow D. Reproduction post chemotherapy in young cancer patients. Mol Cell Endocrinology. 2000; 169:123–31.

5 5 Haukvik UK, Dieset I, Bjoro T, Holte H, Fossa SD. Treatment‐related premature ovarian failure as a long‐ term complication after Hodgkin’s lymphoma. Ann Oncol. 2006; 17(9):1428–33.

6 6 Hodgson DC, Pintilie M, Gitterman L, et al. Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol. 2007; 25(1):11–15.

7 7 Brusamolino E, Baio A, Orlandi E, et al. Long‐term events in adult patients with clinical stage IA‐IIA non bulky Hodgkin’s lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single‐institution 15‐year follow‐up. Clin Cancer Res. 2006; 12(21):6487–93.

8 8 Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti‐Mullerian hormone follow‐up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online. 2010; 20(2):280–5.

9 9 Yuksel A, Bildik G, Senbabaoglu F, et al. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Hum Reprod. 2015; 30(12):2926–35.

10 10 Iqbal J, Amir E, Rochon PA, Giannakeas V, Sun P, Narod SA. Association of the timing of pregnancy with survival in women with breast cancer. JAMA Oncol. 2017 May; 3(5):659–65.

11 11 Berger JC, Clericuzio CL. Pierre Robin Sequence associated with Tamoxifen exposure. Am J Med Genet A. 2008; 146(16):2141–4.

12 12 Braems G, Denys H, Wever O, Cocqut V, Van den Broecke R. Use of Tamoxifen before and during pregnancy. Oncologist. 2011; 16:1547–51.

13 13 Anderson RA, Remedios R, Kirkwood AA, Johnson PWM et al. Determinants of ovarian function after response‐adapted therapy in patients with advanced Hodgkin’s Lymphoma (RATHL): a secondary analysis of a randomized phase 3 trial. Lancet Oncol. 2018; 19:1328–37.

14 14 Goldrat O. Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O et al. Pregnancy following breast cancer using assisted reproduction and its effect on long term outcome. Eur J Cancer. 2015; 51:1490–6.

15 15 Lambertinin M. KromanN, Ameye L. et al. Long term safety of pregnancy following breast cancer according to oestrogen receptor status. J Natl Cancer Inst. 2018; 110:426–9.

16 16 Poirot C, Fortin A, Dhédin N, Brice P, Socié G, Boissel N et al. Post‐transplant outcome of ovarian tissue cryopreserved after chemotherapy in haematologic malignancies. Haematologica. 2019; 104(8):e360–3.

17 17 Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Asstd Reprod Genet. 2013; 30(1):11–24.

18 18 Hodgson DC. Long‐term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients. Clinical Advances in Haematology & Oncology. 2015;13(2).

19 19 Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect.” Am J Obstet Gynaecol. 1994; 170:818–23.

20 20 Lambertini M, Moore HCF, Leonard RCF, Del Mastro L et al. Gonadotropin‐releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta‐analysis of individual patient‐level data. J Clin Oncol. 2018; 36(19):1981–90.

21 21 Demeestere I, Brice P, Peccatori FA, et al. No evidence for the benefit of gonadotropin‐releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long‐term report of a prospective randomized trial. J Clin Oncol. 2016; 34:2568–74.

22 22 Reddy N, Furness CL, Davies MC. Fertility in the adolescent and young adult patient with cancer. In: Chisholm J, Hough R, Soanes L, eds. A Practical Approach to the Care of Adolescents and Young Adults with Cancer. New York:Springer;2018.